Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Choosing Wisely: Optimizing Outpatient Cancer Care and Conserving Resources with a New Algorithm to Report Automated ANC Results in the Presence of Analyzer Flags

Maly Fenelus, MD MPH, Ryan M Golden, MLS(ASCP), Tamiqua Graham, MLS(ASCP), Rachel J So, Jessica Lynn Bautista, BS, MT(ASCP), Ellinor I.B. Peerschke, PhD

Blood (2019) 134 (Supplement_1): 4683.

https://doi.org/10.1182/blood-2019-128963

Published: 2019

Journal Articles

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Vasily Shuvaev, MD, Karina Krutikova, MD, Svetlana Menshakova, MD, Natalya Kalinova, MD, Irina Martynkevich, MD PhD, Lyubov Polushkina, MD, Elena Belyakova, MD, Yury Krivolapov, MD PhD, Sergei Voloshin, MD PhD

Blood (2018) 132 (Supplement 1): 5483.

https://doi.org/10.1182/blood-2018-99-114885

Published: 2018

Journal Articles

Atypical basophilia

Henk-Jan Boiten, Eva de Jongh

Blood (2018) 132 (5): 551.

https://doi.org/10.1182/blood-2018-05-849901

Published: 2018

Journal Articles

B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with t(5;14)(q31;q32)/ IL3-IGH Rearrangement and Eosinophilia: A Peculiar IGH BCP-ALL

Blood (2017) 130 (Supplement 1): 2572.

https://doi.org/10.1182/blood.V130.Suppl_1.2572.2572

Published: 2017

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Patient Derived Xenotransplantation Model of Atypical Chronic Myeloid Leukemia (aCML)

Arnold Kloos, PhD, Felicitas Thol, MD, Sabrina Klesse, Alessandro Liebich, Arne Trummer, MD, Renate Schottmann, Rubén Trespando Jiménez, Gudrun Göhring, MD, Brigitte Schlegelberger, MD PhD, Arnold Ganser, MD, Michael Heuser, MD

Blood (2015) 126 (23): 2836.

https://doi.org/10.1182/blood.V126.23.2836.2836

Published: 2015

Journal Articles

Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease

Philip A Beer, MRCP, FRCPath, PhD, Ivan Sloma, PhD, Paul H Miller, BAppSc, David JHF Knapp, BSc, Gabrielle Rabu, BSc, Connie J Eaves, PhD

Blood (2013) 122 (21): 513.

https://doi.org/10.1182/blood.V122.21.513.513

Published: 2013

Journal Articles

Eosinophil Chimerism In The Differential Diagnosis Between DEK-CAN+ Acute Myeloid Leukemia Relapse and Chronic Graft Versus Host Disease

Clarissa L.M. Souza, MD, Carolina B Bub, MD, Elvira RP Velloso, MD, PhD, Paulo A.A. Silveira, MD PhD, Juliana F Fernandes, MD, Vicente Odone, MD, PhD, Nelson Hamerschlak, MD, PhD, Nydia Bacal, MD, Paulo Vidal Campregher, MD

Blood (2013) 122 (21): 5004.

https://doi.org/10.1182/blood.V122.21.5004.5004

Published: 2013

Journal Articles

Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome

Caroline Irene Piatek, M.D., Maria E. Vergara-Lluri, M.D., Vinod Pullarkat, MD, Imran N. Siddiqi, M.D, Ph.D., Casey O'Connell, MD, Donald I. Feinstein, MD, Russell K. Brynes, MD

Blood (2013) 122 (21): 3714.

https://doi.org/10.1182/blood.V122.21.3714.3714

Published: 2013

Journal Articles

Targeted Therapy in CMML: Complete Molecular Response to Sorafenib in a Patient with a FLT3-ITD Malignant Hematopoiesis

Olivier Kosmider, MD, PhD, Nicolas Chapuis, Sophie Kaltenbach, Romain Coriat, Pascaline boudou-Rouquette, Lise Willems, Virginie Chesnais, Isabelle Radford-Weiss, Valérie Bardet, Patrick Mayeux, Jerome Tamburini, Michaela Fontenay, MD, PhD, Didier Bouscary

Blood (2012) 120 (21): 4786.

https://doi.org/10.1182/blood.V120.21.4786.4786

Published: 2012

Journal Articles

A Four-Way Translocation t (1;17; 9; 22) (p?35; q24; q34;q11) in a Newly Diagnosed Chronic Phase CML Patient: A Case Report

Eloísa Riva, MD, Rosina Fernandez, BSc, Adriana Gonzalez, BSc, Gonzalo Manrique, MsC, Ricardo Germano, MD, Maria de los Angeles Novoa, MD, Virginia Costa, MD, Santiago Pomoli, MD, M. Rosario Uriarte Escuder, PhD, Cynthia de Almeida, MD, PhD

Blood (2012) 120 (21): 4459.

https://doi.org/10.1182/blood.V120.21.4459.4459

Published: 2012

Journal Articles

CML Shows Characteristic Pattern by Flow Cytometry Analysis of Peripheral Blood

Kalley Scott, Wojciech Gorczyca, MD, PhD

Blood (2012) 120 (21): 4430.

https://doi.org/10.1182/blood.V120.21.4430.4430

Published: 2012

Journal Articles

Translocation t(6;9)(p22;q34)/DEK-NUP214 rearranged Pediatric AML: A Retrospective International Study

Blood (2012) 120 (21): 538.

https://doi.org/10.1182/blood.V120.21.538.538

Published: 2012

Journal Articles

Pomalidomide in Myelofibrosis with Cytopenia: First Results of the Mpnsg 01–09 Study (ClinicalTrials.gov Identifier: NCT00949364).

Blood (2012) 120 (21): 2840.

https://doi.org/10.1182/blood.V120.21.2840.2840

Published: 2012

Journal Articles

Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.

Pilar Palomo Moraleda, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Yaddanapudi Ravindranath, MD, Beverly Lange, MD, William G. Woods, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2541.

https://doi.org/10.1182/blood.V120.21.2541.2541

Published: 2012

Journal Articles

Serum Tryptase Is a Strong Predictive Biomarker That Improves Prognostication in Ph+ Chronic Myeloid Leukemia.

Wolfgang R. Sperr, M.D., Thomas Pfeiffer, Michael Kundi, MD, Christian Sillaber, MD, Susanne Herndlhofer, Peter Valent, MD

Blood (2012) 120 (21): 2783.

https://doi.org/10.1182/blood.V120.21.2783.2783

Published: 2012

Journal Articles

Mutational Analysis of N-Ras Proto-Oncogene in Acute Myeloid Leukemia: A Study of 70 Adult Korean Patients

Jihun Jeong, Jeong Yeal Ahn, Jae Hoon Lee, MD

Blood (2011) 118 (21): 4883.

https://doi.org/10.1182/blood.V118.21.4883.4883

Published: 2011

Journal Articles

Upfront Imatinib in Pediatric Chronic Myeloid Leukemia Yields Results Comparable to Stem Cell Transplant,

Prasanth Ganesan, MD, Tenali Gnana Sagar, MD, Krishnarathnam Kannan, MD, Rejiv Rajendranath, MD

Blood (2011) 118 (21): 3763.

https://doi.org/10.1182/blood.V118.21.3763.3763

Published: 2011

Journal Articles

A Phase-2 Trial of Low-Dose Pomalidomide In Myelofibrosis with Anemia

Kebede Begna, MD, Ruben A. Mesa, MD, Animesh Pardanani, MBBS, PhD, William J Hogan, MBBCh, Mark R. Litzow, MD, Rebecca F McClure, MD, Ayalew Tefferi, MD

Blood (2010) 116 (21): 4109.

https://doi.org/10.1182/blood.V116.21.4109.4109

Published: 2010

Journal Articles

Chronic Idiopathic Neutrophilia: Retrospective Analysis of Causes and Consequences

Rafael Arteta-Bulos, Fellow, MD, Alva B. Weir, III, MD, FACP, James Lewis, MD

Blood (2010) 116 (21): 4717.

https://doi.org/10.1182/blood.V116.21.4717.4717

Published: 2010

NARROW

Choosing Wisely: Optimizing Outpatient Cancer Care and Conserving Resources with a New Algorithm to Report Automated ANC Results in the Presence of Analyzer Flags

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Atypical basophilia

B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with t(5;14)(q31;q32)/ IL3-IGH Rearrangement and Eosinophilia: A Peculiar IGH BCP-ALL

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Patient Derived Xenotransplantation Model of Atypical Chronic Myeloid Leukemia (aCML)

Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease

Eosinophil Chimerism In The Differential Diagnosis Between DEK-CAN+ Acute Myeloid Leukemia Relapse and Chronic Graft Versus Host Disease

Autoimmune Myelofibrosis (AIMF) – Clinical Features, Course and Outcome

Targeted Therapy in CMML: Complete Molecular Response to Sorafenib in a Patient with a FLT3-ITD Malignant Hematopoiesis

A Four-Way Translocation t (1;17; 9; 22) (p?35; q24; q34;q11) in a Newly Diagnosed Chronic Phase CML Patient: A Case Report

CML Shows Characteristic Pattern by Flow Cytometry Analysis of Peripheral Blood

Translocation t(6;9)(p22;q34)/DEK-NUP214 rearranged Pediatric AML: A Retrospective International Study

Pomalidomide in Myelofibrosis with Cytopenia: First Results of the Mpnsg 01–09 Study (ClinicalTrials.gov Identifier: NCT00949364).

Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.

Serum Tryptase Is a Strong Predictive Biomarker That Improves Prognostication in Ph+ Chronic Myeloid Leukemia.

Mutational Analysis of N-Ras Proto-Oncogene in Acute Myeloid Leukemia: A Study of 70 Adult Korean Patients

Upfront Imatinib in Pediatric Chronic Myeloid Leukemia Yields Results Comparable to Stem Cell Transplant,

A Phase-2 Trial of Low-Dose Pomalidomide In Myelofibrosis with Anemia

Chronic Idiopathic Neutrophilia: Retrospective Analysis of Causes and Consequences

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only